Bezlotoxumab
| PK/PD Index | No data |
|---|---|
| Pharmaceutical Preparations | Injection |
| Food Rec (PO Drugs) 1 | - |
| Oral Absorption (%) | - |
| Tmax (hr) | - |
| Peak Serum Conc (µg/mL) 2 | 185 (10 mg/kg IV, SD) |
| Peak Urine Conc (µg/mL) | No data |
| Protein Binding (%) | No data |
| Volume of Distribution (Vd) 3 | 7.33 L |
| Avg Serum T½ (hr) 4 | 19 days |
| Elimination | Catabolism |
| Bile Penetration (%) 5 | No data |
| CSF/blood (%) 6 | No data |
| Therapeutic Levels in CSF 7 | No data |
| AUC (µg*hr/mL) 8 | 53000 (10 mg/kg IV, 0-inf) |